Clinical Trial

Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy Specimen

Study acronym: IMARHGIN
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 7, 2025 (before its estimated May 13, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study investigates a new, faster way to find cancer cells on the surface of the prostate during radical prostatectomy surgery. A recently FDA-approved device, called the Histolog Scanner, gives high-resolution imaging of the surface of fresh tissue using ultra-fast confocal microscopy, which allows physicians to make surgical decisions quickly.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-18.
Trial Details
NCT Number NCT07141121
Lead Sponsor Icahn School of Medicine at Mount Sinai
Collaborators: SamanTree Medical SA
Conditions Prostate Cancer
Enrollment 78 participants
Start Date 2025-05-13
Primary Completion 2026-05-13 (estimated)
Study Completion 2026-05-13 (estimated)
Updated on ClinicalTrials.gov 2025-10-07